Cellcept is a prescription medicine used to prevent organ rejection in people who have received kidney, heart, and liver transplants. Rejection is when the body's immune system perceives the new organ as a "foreign" threat and attacks it. Cellcept belongs to a group of drugs called immunosuppressive agents. It works by weakening the body's immune system so it doesn't attack the new organ.
WARNING
Immunosuppression may lead to increased susceptibility to infection and possible development of lymphoma. Only physicians experienced in immunosuppressive therapy and management of renal, cardiac or hepatic transplant patients should use Cellcept . Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.
Female users of childbearing potential must use contraception. Use of Cellcept during pregnancy is associated with increased risk of pregnancy loss and congenital malformations.
